These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34201610)

  • 21. The β-turn-supporting motif in the polyglutamine binding peptide QBP1 is essential for inhibiting huntingtin aggregation.
    Belwal VK; Datta D; Chaudhary N
    FEBS Lett; 2020 Sep; 594(17):2894-2903. PubMed ID: 32592593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-assembly of Mutant Huntingtin Exon-1 Fragments into Large Complex Fibrillar Structures Involves Nucleated Branching.
    Wagner AS; Politi AZ; Ast A; Bravo-Rodriguez K; Baum K; Buntru A; Strempel NU; Brusendorf L; Hänig C; Boeddrich A; Plassmann S; Klockmeier K; Ramirez-Anguita JM; Sanchez-Garcia E; Wolf J; Wanker EE
    J Mol Biol; 2018 Jun; 430(12):1725-1744. PubMed ID: 29601786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SUMOylation Prevents Huntingtin Fibrillization and Localization onto Lipid Membranes.
    Sedighi F; Adegbuyiro A; Legleiter J
    ACS Chem Neurosci; 2020 Feb; 11(3):328-343. PubMed ID: 31880908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer.
    Sahoo B; Arduini I; Drombosky KW; Kodali R; Sanders LH; Greenamyre JT; Wetzel R
    PLoS One; 2016; 11(6):e0155747. PubMed ID: 27271685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monomeric Huntingtin Exon 1 Has Similar Overall Structural Features for Wild-Type and Pathological Polyglutamine Lengths.
    Warner JB; Ruff KM; Tan PS; Lemke EA; Pappu RV; Lashuel HA
    J Am Chem Soc; 2017 Oct; 139(41):14456-14469. PubMed ID: 28937758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Intein-based Strategy for the Production of Tag-free Huntingtin Exon 1 Proteins Enables New Insights into the Polyglutamine Dependence of Httex1 Aggregation and Fibril Formation.
    Vieweg S; Ansaloni A; Wang ZM; Warner JB; Lashuel HA
    J Biol Chem; 2016 Jun; 291(23):12074-86. PubMed ID: 27002149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
    Huang CC; Faber PW; Persichetti F; Mittal V; Vonsattel JP; MacDonald ME; Gusella JF
    Somat Cell Mol Genet; 1998 Jul; 24(4):217-33. PubMed ID: 10410676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Huntingtin disrupts lipid bilayers in a polyQ-length dependent manner.
    Burke KA; Hensal KM; Umbaugh CS; Chaibva M; Legleiter J
    Biochim Biophys Acta; 2013 Aug; 1828(8):1953-61. PubMed ID: 23643759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The folding equilibrium of huntingtin exon 1 monomer depends on its polyglutamine tract.
    Bravo-Arredondo JM; Kegulian NC; Schmidt T; Pandey NK; Situ AJ; Ulmer TS; Langen R
    J Biol Chem; 2018 Dec; 293(51):19613-19623. PubMed ID: 30315108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new Caenorhabditis elegans model of human huntingtin 513 aggregation and toxicity in body wall muscles.
    Lee AL; Ung HM; Sands LP; Kikis EA
    PLoS One; 2017; 12(3):e0173644. PubMed ID: 28282438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease models.
    Daldin M; Fodale V; Cariulo C; Azzollini L; Verani M; Martufi P; Spiezia MC; Deguire SM; Cherubini M; Macdonald D; Weiss A; Bresciani A; Vonsattel JG; Petricca L; Marsh JL; Gines S; Santimone I; Marano M; Lashuel HA; Squitieri F; Caricasole A
    Sci Rep; 2017 Jul; 7(1):5070. PubMed ID: 28698602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoscale studies link amyloid maturity with polyglutamine diseases onset.
    Ruggeri FS; Vieweg S; Cendrowska U; Longo G; Chiki A; Lashuel HA; Dietler G
    Sci Rep; 2016 Aug; 6():31155. PubMed ID: 27499269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphomimetic Mutations Impact Huntingtin Aggregation in the Presence of a Variety of Lipid Systems.
    Groover SE; Beasley M; Ramamurthy V; Legleiter J
    Biochemistry; 2020 Dec; 59(49):4681-4693. PubMed ID: 33256402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation of huntingtin at residue T3 is decreased in Huntington's disease and modulates mutant huntingtin protein conformation.
    Cariulo C; Azzollini L; Verani M; Martufi P; Boggio R; Chiki A; Deguire SM; Cherubini M; Gines S; Marsh JL; Conforti P; Cattaneo E; Santimone I; Squitieri F; Lashuel HA; Petricca L; Caricasole A
    Proc Natl Acad Sci U S A; 2017 Dec; 114(50):E10809-E10818. PubMed ID: 29162692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyglutamine expansion diseases: More than simple repeats.
    Silva A; de Almeida AV; Macedo-Ribeiro S
    J Struct Biol; 2018 Feb; 201(2):139-154. PubMed ID: 28928079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Huntingtin Polyglutamine-Dependent Protein Aggregation in Reconstituted Cells.
    Machida K; Kanzawa K; Shigeta T; Yamamoto Y; Tsumoto K; Imataka H
    ACS Synth Biol; 2018 Feb; 7(2):377-383. PubMed ID: 29232946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of polyglutamine aggregation by SIMILAR huntingtin N-terminal sequences: Prospective molecules for preclinical evaluation in Huntington's disease.
    Burra G; Thakur AK
    Biopolymers; 2017 Jul; 108(4):. PubMed ID: 28406522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract.
    Hazeki N; Nakamura K; Goto J; Kanazawa I
    Biochem Biophys Res Commun; 1999 Mar; 256(2):361-6. PubMed ID: 10079189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.
    Banerjee M; Datta M; Bhattacharyya NP
    Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. All-atom stability and oligomerization simulations of polyglutamine nanotubes with and without the 17-amino-acid N-terminal fragment of the Huntingtin protein.
    Côté S; Wei G; Mousseau N
    J Phys Chem B; 2012 Oct; 116(40):12168-79. PubMed ID: 22978784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.